Journal of Shanghai Jiao Tong University (Medical Science) ›› 2024, Vol. 44 ›› Issue (1): 137-144.doi: 10.3969/j.issn.1674-8115.2024.01.016
• Review • Previous Articles
Received:
2023-09-06
Accepted:
2024-04-18
Online:
2024-01-28
Published:
2024-02-28
Contact:
ZHANG Jing
E-mail:zhaixia000@163.com;jing5522724@163.com
Supported by:
CLC Number:
ZHOU Haixia, ZHANG Jing. Research progress of m6A methylation modification in regulating tumor immunity[J]. Journal of Shanghai Jiao Tong University (Medical Science), 2024, 44(1): 137-144.
Add to citation manager EndNote|Ris|BibTeX
URL: https://xuebao.shsmu.edu.cn/EN/10.3969/j.issn.1674-8115.2024.01.016
Immune cell | m6A regulator | Type | Related factor | Function | Reference |
---|---|---|---|---|---|
DC | METTL3 | Writer | CD40, CD80 and Tirap | Positively correlates with DC maturation and function in promoting T-cell activation | [ |
YTHDF1 | Reader | Lysosomal proteases | Negatively correlates with cross-presentation of engulfed tumour neoantigens | [ | |
YTHDF2 | Reader | lnc-Dpf3 | Positively correlates with DC migration | [ | |
NK | METTL3 | Writer | SHP-2 | Positively correlates antitumor immunity of NK cells | [ |
YTHDF2 | Reader | Tardb | Positively correlates with NK cell antitumor activity as well as NK cell homeostasis and maturation | [ | |
TAM | METTL3 | Writer | STAT1, STAT3 | Positively correlates with M1 macrophage polarization | [ |
YTHDF2 | Reader | STAT1 | Negatively correlates with macrophage reprogramming and antitumor immunity | [ | |
Monocyte | METTL3 | Writer | PGC-1α | Positively correlates with monocyte differentiation into different types of macrophages | [ |
Neutrophil | WTAP | Writer | ENO1 | Positively correlates with tumor glycolysis mediated by C5aR1-positive neutrophils | [ |
FTO | Eraser | ZEB1 | Positively correlates with senescent neutrophils-mediated chemoresistance in breast cancer | [ | |
MDSC | METTL3 | Writer | BHLHE41 | Positively correlates with MDSC migration | [ |
YTHDF1 | Reader | EZH2 | Positively correlates with MDSC recruitment and activation | [ | |
γδ T cell | METTL3 | Writer | STAT1 | Positively correlates with equilibrate γδ T1 and γδ T17 cells | [ |
ALKBH5 | Eraser | Jagged1/Notch2 | Negatively correlates with proliferation and differentiation of γδ T cell precursors | [ | |
Mast cell | METTL3 | Writer | IL-13 | Negatively correlates with inflammatory responses of mast cells | [ |
Tab 1 Role of m6A modifications in innate immune cells
Immune cell | m6A regulator | Type | Related factor | Function | Reference |
---|---|---|---|---|---|
DC | METTL3 | Writer | CD40, CD80 and Tirap | Positively correlates with DC maturation and function in promoting T-cell activation | [ |
YTHDF1 | Reader | Lysosomal proteases | Negatively correlates with cross-presentation of engulfed tumour neoantigens | [ | |
YTHDF2 | Reader | lnc-Dpf3 | Positively correlates with DC migration | [ | |
NK | METTL3 | Writer | SHP-2 | Positively correlates antitumor immunity of NK cells | [ |
YTHDF2 | Reader | Tardb | Positively correlates with NK cell antitumor activity as well as NK cell homeostasis and maturation | [ | |
TAM | METTL3 | Writer | STAT1, STAT3 | Positively correlates with M1 macrophage polarization | [ |
YTHDF2 | Reader | STAT1 | Negatively correlates with macrophage reprogramming and antitumor immunity | [ | |
Monocyte | METTL3 | Writer | PGC-1α | Positively correlates with monocyte differentiation into different types of macrophages | [ |
Neutrophil | WTAP | Writer | ENO1 | Positively correlates with tumor glycolysis mediated by C5aR1-positive neutrophils | [ |
FTO | Eraser | ZEB1 | Positively correlates with senescent neutrophils-mediated chemoresistance in breast cancer | [ | |
MDSC | METTL3 | Writer | BHLHE41 | Positively correlates with MDSC migration | [ |
YTHDF1 | Reader | EZH2 | Positively correlates with MDSC recruitment and activation | [ | |
γδ T cell | METTL3 | Writer | STAT1 | Positively correlates with equilibrate γδ T1 and γδ T17 cells | [ |
ALKBH5 | Eraser | Jagged1/Notch2 | Negatively correlates with proliferation and differentiation of γδ T cell precursors | [ | |
Mast cell | METTL3 | Writer | IL-13 | Negatively correlates with inflammatory responses of mast cells | [ |
Immune cell | m6A regulator | Type | Related factor | Function | Reference |
---|---|---|---|---|---|
CD4+ T cell | METTL3 | Writer | SOCS | Positively correlates with proliferation and differentiation of T cells | [ |
ALKBH5 | Eraser | IFN-γ, CXCL2 | Positively correlates with Th1 cell activation | [ | |
Treg cell | METTL3 | Writer | SOCS | Positively correlates with sustaining Treg suppressive functions | [ |
METTL14 | Writer | RORγt | Positively correlates with Tregs differentiation | [ | |
CD8+ T cell | METTL3 | Writer | circIGF2BP3 | Negatively correlates with CD8+T cell responses and facilitates tumor immune | [ |
METTL14 | Writer | Ebi3 | Negatively correlates with dysfunctional CD8+T cell levels in patients with colorectal cancer | [ | |
YTHDF1/2 | Reader | unkown | Positively correlates with tumor-infiltrating lymphocytes, including CD8+ T cells | [ | |
FTO | Eraser | c-Jun, JunB, and C/EBPβ | Positively correlates with glycolytic metabolism of tumor cells; negatively correlates with CD8+T cell responses | [ | |
B cell | METTL14 | Writer | Lax1, Tipe2 | Positively correlates with B cell maturation | [ |
FTO | Eraser | HSF1 | Positively correlates with tumor-promoting and pro-metastatic in multiple myeloma | [ |
Tab 2 Role of m6A modifications in adaptive immune cells
Immune cell | m6A regulator | Type | Related factor | Function | Reference |
---|---|---|---|---|---|
CD4+ T cell | METTL3 | Writer | SOCS | Positively correlates with proliferation and differentiation of T cells | [ |
ALKBH5 | Eraser | IFN-γ, CXCL2 | Positively correlates with Th1 cell activation | [ | |
Treg cell | METTL3 | Writer | SOCS | Positively correlates with sustaining Treg suppressive functions | [ |
METTL14 | Writer | RORγt | Positively correlates with Tregs differentiation | [ | |
CD8+ T cell | METTL3 | Writer | circIGF2BP3 | Negatively correlates with CD8+T cell responses and facilitates tumor immune | [ |
METTL14 | Writer | Ebi3 | Negatively correlates with dysfunctional CD8+T cell levels in patients with colorectal cancer | [ | |
YTHDF1/2 | Reader | unkown | Positively correlates with tumor-infiltrating lymphocytes, including CD8+ T cells | [ | |
FTO | Eraser | c-Jun, JunB, and C/EBPβ | Positively correlates with glycolytic metabolism of tumor cells; negatively correlates with CD8+T cell responses | [ | |
B cell | METTL14 | Writer | Lax1, Tipe2 | Positively correlates with B cell maturation | [ |
FTO | Eraser | HSF1 | Positively correlates with tumor-promoting and pro-metastatic in multiple myeloma | [ |
1 | YI Y C, CHEN X Y, ZHANG J, et al. Novel insights into the interplay between m6A modification and noncoding RNAs in cancer[J]. Mol Cancer, 2020, 19(1): 121. |
2 | SHULMAN Z, STERN-GINOSSAR N. The RNA modification N6-methyladenosine as a novel regulator of the immune system[J]. Nat Immunol, 2020, 21(5): 501-512. |
3 | WANG X, LU Z K, GOMEZ A, et al. N6-methyladenosine-dependent regulation of messenger RNA stability[J]. Nature, 2014, 505(7481): 117-120. |
4 | LI A, CHEN Y S, PING X L, et al. Cytoplasmic m6A reader YTHDF3 promotes mRNA translation[J]. Cell Res, 2017, 27(3): 444-447. |
5 | ROUNDTREE I A, EVANS M E, PAN T, et al. Dynamic RNA modifications in gene expression regulation[J]. Cell, 2017, 169(7): 1187-1200. |
6 | DENG L J, DENG W Q, FAN S R, et al. m6A modification: recent advances, anticancer targeted drug discovery and beyond[J]. Mol Cancer, 2022, 21(1): 52. |
7 | JIA G F, FU Y, ZHAO X, et al. N6-methyladenosine in nuclear RNA is a major substrate of the obesity-associated FTO[J]. Nat Chem Biol, 2011, 7(12): 885-887. |
8 | ZHENG G Q, DAHL J A, NIU Y M, et al. ALKBH5 is a mammalian RNA demethylase that impacts RNA metabolism and mouse fertility[J]. Mol Cell, 2013, 49(1): 18-29. |
9 | MORANTE-PALACIOS O, FONDELLI F, BALLESTAR E, et al. Tolerogenic dendritic cells in autoimmunity and inflammatory diseases[J]. Trends Immunol, 2021, 42(1): 59-75. |
10 | DIAMOND M S, LIN J H, VONDERHEIDE R H. Site-dependent immune escape due to impaired dendritic cell cross-priming[J]. Cancer Immunol Res, 2021, 9(8): 877-890. |
11 | WANG H M, HU X, HUANG M Y, et al. Mettl3-mediated mRNA m6A methylation promotes dendritic cell activation[J]. Nat Commun, 2019, 10(1): 1898. |
12 | LIU J, ZHANG X M, CHEN K, et al. CCR7 chemokine receptor-inducible lnc-Dpf3 restrains dendritic cell migration by inhibiting HIF-1α-mediated glycolysis[J]. Immunity, 2019, 50(3): 600-615.e15. |
13 | HAN D L, LIU J, CHEN C Y, et al. Anti-tumour immunity controlled through mRNA m6A methylation and YTHDF1 in dendritic cells[J]. Nature, 2019, 566(7743): 270-274. |
14 | WU S Y, FU T, JIANG Y Z, et al. Natural killer cells in cancer biology and therapy[J]. Mol Cancer, 2020, 19(1): 120. |
15 | SONG H, SONG J X, CHENG M, et al. METTL3-mediated m6A RNA methylation promotes the anti-tumour immunity of natural killer cells[J]. Nat Commun, 2021, 12(1): 5522. |
16 | MA S B, YAN J Z, BARR T, et al. The RNA m6A reader YTHDF2 controls NK cell antitumor and antiviral immunity[J]. J Exp Med, 2021, 218(8): e20210279. |
17 | LEWIS C E, POLLARD J W. Distinct role of macrophages in different tumor microenvironments[J]. Cancer Res, 2006, 66(2): 605-612. |
18 | CAUX C, RAMOS R N, PRENDERGAST G C, et al. A milestone review on how macrophages affect tumor growth[J]. Cancer Res, 2016, 76(22): 6439-6442. |
19 | PITTET M J, MICHIELIN O, MIGLIORINI D. Clinical relevance of tumour-associated macrophages[J]. Nat Rev Clin Oncol, 2022, 19(6): 402-421. |
20 | LIU Y H, LIU Z J, TANG H, et al. The N 6-methyladenosine (m6A)-forming enzyme METTL3 facilitates M1 macrophage polarization through the methylation of STAT1 mRNA[J]. Am J Physiol Cell Physiol, 2019, 317(4): C762-C775. |
21 | YIN H L, ZHANG X, YANG P Y, et al. RNA m6A methylation orchestrates cancer growth and metastasis via macrophage reprogramming[J]. Nat Commun, 2021, 12(1): 1394. |
22 | MA S B, SUN B F, DUAN S Q, et al. YTHDF2 orchestrates tumor-associated macrophage reprogramming and controls antitumor immunity through CD8+ T cells[J]. Nat Immunol, 2023, 24(2): 255-266. |
23 | OLINGY C E, DINH H Q, HEDRICK C C. Monocyte heterogeneity and functions in cancer[J]. J Leukoc Biol, 2019, 106(2): 309-322. |
24 | XIE J Y, HUANG Z J, JIANG P, et al. Elevated N6-methyladenosine RNA levels in peripheral blood immune cells: a novel predictive biomarker and therapeutic target for colorectal cancer[J]. Front Immunol, 2021, 12: 760747. |
25 | ZHANG X N, LI X, JIA H T, et al. The m6A methyltransferase METTL3 modifies PGC-1α mRNA promoting mitochondrial dysfunction and oxLDL-induced inflammation in monocytes[J]. J Biol Chem, 2021, 297(3): 101058. |
26 | JAILLON S, PONZETTA A, MITRI D D, et al. Neutrophil diversity and plasticity in tumour progression and therapy[J]. Nat Rev Cancer, 2020, 20(9): 485-503. |
27 | OU B C, LIU Y, YANG X W, et al. C5aR1-positive neutrophils promote breast cancer glycolysis through WTAP-dependent m6A methylation of ENO1[J]. Cell Death Dis, 2021, 12(8): 737. |
28 | OU B C, LIU Y, GAO Z X, et al. Senescent neutrophils-derived exosomal piRNA-17560 promotes chemoresistance and EMT of breast cancer via FTO-mediated m6A demethylation[J]. Cell Death Dis, 2022, 13(10): 905. |
29 | VEGLIA F, SANSEVIERO E, GABRILOVICH D I. Myeloid-derived suppressor cells in the era of increasing myeloid cell diversity[J]. Nat Rev Immunol, 2021, 21(8): 485-498. |
30 | CHEN H R, PAN Y S, ZHOU Q M, et al. METTL3 inhibits antitumor immunity by targeting m6A-BHLHE41-CXCL1/CXCR2 axis to promote colorectal cancer[J]. Gastroenterology, 2022, 163(4): 891-907. |
31 | WANG L N, ZHU L F, LIANG C, et al. Targeting N6-methyladenosine reader YTHDF1 with siRNA boosts antitumor immunity in NASH-HCC by inhibiting EZH2-IL-6 axis[J]. J Hepatol, 2023, 79(5): 1185-1200. |
32 | SILVA-SANTOS B, MENSURADO S, COFFELT S B. γδ T cells: pleiotropic immune effectors with therapeutic potential in cancer[J]. Nat Rev Cancer, 2019, 19(7): 392-404. |
33 | DING C B, XU H, YU Z B, et al. RNA m6A demethylase ALKBH5 regulates the development of γδ T cells[J]. Proc Natl Acad Sci U S A, 2022, 119(33): e2203318119. |
34 | XIAO Z Q, WANG S S, TIAN Y X, et al. METTL3-mediated m6A methylation orchestrates mRNA stability and dsRNA contents to equilibrate γδ T1 and γδ T17 cells[J]. Cell Rep, 2023, 42(7): 112684. |
35 | LICHTERMAN J N, REDDY S M. Mast cells: a new frontier for cancer immunotherapy[J]. Cells, 2021, 10(6): 1270. |
36 | GUO W, TAN F W, HUAI Q L, et al. Comprehensive analysis of PD-L1 expression, immune infiltrates, and m6A RNA methylation regulators in esophageal squamous cell carcinoma[J]. Front Immunol, 2021, 12: 669750. |
37 | XU Z Y, CHEN Q L, SHU L L, et al. Expression profiles of m6A RNA methylation regulators, PD-L1 and immune infiltrates in gastric cancer[J]. Front Oncol, 2022, 12: 970367. |
38 | LEONI C, BATACLAN M, ITO-KUREHA T, et al. The mRNA methyltransferase Mettl3 modulates cytokine mRNA stability and limits functional responses in mast cells[J]. Nat Commun, 2023, 14(1): 3862. |
39 | WALSH S R, SIMOVIC B, CHEN L, et al. Endogenous T cells prevent tumor immune escape following adoptive T cell therapy[J]. J Clin Invest, 2019, 129(12): 5400-5410. |
40 | SI J W, SHI X J, SUN S H, et al. Hematopoietic progenitor kinase1 (HPK1) mediates T cell dysfunction and is a druggable target for T cell-based immunotherapies[J]. Cancer Cell, 2020, 38(4): 551-566.e11. |
41 | BORST J, AHRENDS T, BĄBAŁA N, et al. CD4+ T cell help in cancer immunology and immunotherapy[J]. Nat Rev Immunol, 2018, 18(10): 635-647. |
42 | LI H B, TONG J Y, ZHU S, et al. m6A mRNA methylation controls T cell homeostasis by targeting the IL-7/STAT5/SOCS pathways[J]. Nature, 2017, 548(7667): 338-342. |
43 | ZHOU J, ZHANG X L, HU J J, et al. m6A demethylase ALKBH5 controls CD4+ T cell pathogenicity and promotes autoimmunity[J]. Sci Adv, 2021, 7(25): eabg0470. |
44 | LU T X, ZHENG Z, ZHANG L D, et al. A new model of spontaneous colitis in mice induced by deletion of an RNA m6A methyltransferase component METTL14 in T cells[J]. Cell Mol Gastroenterol Hepatol, 2020, 10(4): 747-761. |
45 | TONG J Y, CAO G C, ZHANG T, et al. m6A mRNA methylation sustains treg suppressive functions[J]. Cell Res, 2018, 28(2): 253-256. |
46 | DONG L H, CHEN C Y, ZHANG Y W, et al. The loss of RNA N6-adenosine methyltransferase Mettl14 in tumor-associated macrophages promotes CD8+ Tcell dysfunction and tumor growth[J]. Cancer Cell, 2021, 39(7): 945-957.e10. |
47 | TSUCHIYA K, YOSHIMURA K, INOUE Y, et al. YTHDF1 and YTHDF2 are associated with better patient survival and an inflamed tumor-immune microenvironment in non-small-cell lung cancer[J]. Oncoimmunology, 2021, 10(1): 1962656. |
48 | LIU Z C, WANG T T, SHE Y L, et al. N6-methyladenosine-modified circIGF2BP3 inhibits CD8+ T-cell responses to facilitate tumor immune evasion by promoting the deubiquitination of PD-L1 in non-small cell lung cancer[J]. Mol Cancer, 2021, 20(1): 105. |
49 | LIU Y, LIANG G H, XU H J, et al. Tumors exploit FTO-mediated regulation of glycolytic metabolism to evade immune surveillance[J]. Cell Metab, 2021, 33(6): 1221-1233.e11. |
50 | LAUMONT C M, NELSON B H. B cells in the tumor microenvironment: multi-faceted organizers, regulators, and effectors of anti-tumor immunity[J]. Cancer Cell, 2023, 41(3): 466-489. |
51 | ZHENG Z, ZHANG L D, CUI X L, et al. Control of early B cell development by the RNA N6-methyladenosine methylation[J]. Cell Rep, 2020, 31(13): 107819. |
52 | HUANG H J, ZHANG G P, RUAN G X, et al. Mettl14-mediated m6A modification is essential for germinal center B cell response[J]. J Immunol, 2022, 208(8): 1924-1936. |
53 | XU A S, ZHANG J S, ZUO L P, et al. FTO promotes multiple myeloma progression by posttranscriptional activation of HSF1 in an m6A-YTHDF2-dependent manner[J]. Mol Ther, 2022, 30(3): 1104-1118. |
54 | WANG L L, HUI H, AGRAWAL K, et al. m6 A RNA methyltransferases METTL3/14 regulate immune responses to anti-PD-1 therapy[J]. EMBO J, 2020, 39(20): e104514. |
55 | BAO Y, ZHAI J N, CHEN H R, et al. Targeting m6A reader YTHDF1 augments antitumour immunity and boosts anti-PD-1 efficacy in colorectal cancer[J]. Gut, 2023, 72(8): 1497-1509. |
56 | HUANG Y, SU R, SHENG Y, et al. Small-molecule targeting of oncogenic FTO demethylase in acute myeloid leukemia[J]. Cancer Cell, 2019, 35(4): 677-691.e10. |
57 | YANKOVA E, BLACKABY W, ALBERTELLA M, et al. Small-molecule inhibition of METTL3 as a strategy against myeloid leukaemia[J]. Nature, 2021, 593(7860): 597-601. |
58 | ZHANG B, WU Q, LI B, et al. m6A regulator-mediated methylation modification patterns and tumor microenvironment infiltration characterization in gastric cancer[J]. Mol Cancer, 2020, 19(1): 53. |
[1] | ZHOU Xiaowen, LI Qian, ZHANG Zhe, SHEN Jianfeng, FAN Xianqun. RBX1 regulates uveal melanoma immune-related genes via STAT1 [J]. Journal of Shanghai Jiao Tong University (Medical Science), 2023, 43(6): 709-717. |
[2] | ZHAO Zhuoming, LIU Zhenhao, LU Manman, ZHANG Yu, XU Linfeng, XIE Lu. Analysis of tumor-related features of non-small cell lung cancer based on TCR repertoire workflow [J]. Journal of Shanghai Jiao Tong University (Medical Science), 2023, 43(12): 1520-1528. |
[3] | LIU Junjun, LU Sumei, ZHANG Bingyang, LI Yongqing, MA Wanshan. Analysis of m6A methylation expression profiles in liver tissue of high-fat diet-induced mouse models of NAFLD [J]. Journal of Shanghai Jiao Tong University (Medical Science), 2023, 43(10): 1227-1235. |
[4] | LU Yu, WANG Hao, BA Qian. Role of gut microbiota in hepatocellular carcinoma: cancer occurrence, progresses and treatments [J]. Journal of Shanghai Jiao Tong University (Medical Science), 2022, 42(7): 939-944. |
[5] | Jing-wei LI, Li-wen WANG, Ling-xi JIANG, Qian ZHAN, Hao CHEN, Bai-yong SHEN. Review of immunosuppressive tumor microenvironment of pancreatic cancer [J]. JOURNAL OF SHANGHAI JIAOTONG UNIVERSITY (MEDICAL SCIENCE), 2021, 41(8): 1103-1108. |
[6] | Xu-xin-yi LING, Yao ZHANG, Hua ZHONG. Research progress in screening non-small cell lung cancer patients who will benefit from immunotherapy [J]. JOURNAL OF SHANGHAI JIAOTONG UNIVERSITY (MEDICAL SCIENCE), 2021, 41(8): 1114-1119. |
[7] | Paerhati NADINA, Yan YAN, Qian-ji CHE, Jing LUO, Xin-nan LIU, Bin LI. Application and prospect of chimeric antigen receptor-modified T cell therapy for glioblastoma [J]. JOURNAL OF SHANGHAI JIAOTONG UNIVERSITY (MEDICAL SCIENCE), 2021, 41(7): 982-986. |
[8] | Yun-fang MA, Li-na PAN, Zhen LI, Bei-li GAO, Jia-an HU, Zhi-hong XU. Exploratory study on downregulation of PD-L1 in KRAS G12V-mutant non-small cell lung cancer cells by selumetinib [J]. JOURNAL OF SHANGHAI JIAOTONG UNIVERSITY (MEDICAL SCIENCE), 2021, 41(6): 741-748. |
[9] | Ling-ling LI, Qian LI, Ming-yu LI, Zheng LIU, Qian-cheng SHEN. Analysis of tumor immune-related differentially expressed genes in adults and children with acute myeloid leukemia [J]. JOURNAL OF SHANGHAI JIAOTONG UNIVERSITY (MEDICAL SCIENCE), 2021, 41(5): 579-587. |
[10] | ZHAO Wei-guang, LIU Zhi-hong. Advances in study of regulation of tumor immune inflammatory microenvironment by cancer-associated fibroblasts [J]. JOURNAL OF SHANGHAI JIAOTONG UNIVERSITY (MEDICAL SCIENCE), 2020, 40(9): 1288-1293. |
[11] | HE Chun-ming, YIN Hang, ZHENG Jia-jie, TANG Jian, FU Yu-jie, ZHAO Xiao-jing. Immunotherapy for lung cancer: immunosuppressive cells and intrapulmonary immunity [J]. JOURNAL OF SHANGHAI JIAOTONG UNIVERSITY (MEDICAL SCIENCE), 2020, 40(8): 1137-1142. |
[12] | LIU Jie, QIU Xiao-chun. Research hotspots and trends of breast cancer stem cells [J]. JOURNAL OF SHANGHAI JIAOTONG UNIVERSITY (MEDICAL SCIENCE), 2020, 40(7): 881-888. |
[13] | DAI Fei, WEI Jin-jin, TANG Xin-yue, CHEN Zheng, LIN Lin. Effect of sublingual immunotherapy on functions of effector T cells and regulatory T cells [J]. JOURNAL OF SHANGHAI JIAOTONG UNIVERSITY (MEDICAL SCIENCE), 2020, 40(5): 626-632. |
[14] | ZHAO Yi-si1, YU Ying-xi1, LIN Shi-hui2, XU Fang1, 2. Advances in the study of T cell immunity in invasive fungal infections secondary to sepsis [J]. , 2019, 39(11): 1325-. |
[15] | LI Xia-yi, ZHENG Lei-zhen. Application of programmed cell death protein 1/programmed death-ligand 1 blockade in advanced gastric cancer treatment [J]. , 2018, 38(10): 1259-. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||